start
hubei
provinc
china
spread
countri
within
month
statist
across
world
report
daili
provid
dynam
perspect
countri
test
hypothesi
vaccin
tuberculosi
bcg
correl
better
outcom
patient
end
combin
inform
demographi
economi
major
chronic
diseas
immun
polici
outcom
filter
fix
date
countri
predetermin
valu
popul
size
number
death
per
million
dpm
altogeth
countri
cover
world
popul
met
criteria
analyz
allow
reliabl
comparison
countri
align
critic
align
threshold
date
dpm
found
year
bcg
admiss
neg
correl
dpm
vari
time
post
align
result
multivari
regress
test
quantit
properti
countri
popul
substanti
domin
contribut
bcg
admiss
year
outcom
analyz
countri
accord
age
group
partit
across
sever
timepoint
reveal
strongest
correl
attribut
coverag
bcg
vaccin
young
popul
year
lesser
degre
middl
age
group
year
bcg
coverag
statu
elderli
year
insignific
specif
signal
attribut
recent
immun
last
year
rather
past
polici
propos
bcg
immun
coverag
especi
among
recent
vaccin
may
contribut
attenu
spread
sever
spread
within
month
countri
across
globe
progress
pandem
countri
estim
daili
report
compil
world
health
organ
public
avail
worldomet
onlin
resourc
countryspecif
report
provid
statist
inform
number
test
perform
confirm
case
number
death
cumul
state
patient
hospit
seriou
critic
condit
along
spread
pandem
countri
impos
polici
social
distanc
measur
mitig
despit
intens
effort
knowledg
viru
fragment
key
epidemiolog
paramet
still
miss
report
death
averag
number
death
per
million
dpm
april
death
toll
remain
reliabl
measur
monitor
spread
progress
diseas
across
countri
european
countri
belgium
spain
itali
dpm
infect
countri
eg
turkey
israel
hungari
closer
world
averag
larg
differ
outcom
even
among
neighbor
countri
eg
spain
portug
like
sole
reflect
differ
regul
impos
countri
initi
phase
epidem
studi
test
possibl
extent
spread
case
associ
statu
tuberculosi
tb
immun
across
world
bacil
vaccin
bcg
contain
live
attenu
strain
mycobacterium
bovi
wide
use
erad
tb
among
broadli
use
vaccin
throughout
centuri
neonat
young
children
despit
wide
use
mani
develop
countri
world
popul
infect
tb
year
constant
reduct
death
due
tb
observ
last
decad
annual
death
exce
substanti
overlap
peopl
hiv
infect
current
bcg
vaccin
provid
entir
popul
countri
high
tb
incid
last
two
decad
numer
countri
chang
polici
restrict
bcg
immun
polici
nonn
born
migrant
high
tb
burden
countri
studi
question
whether
longrang
impact
bcg
vaccin
regim
vari
fraction
popul
cover
bcg
differ
countri
link
improv
outcom
data
extract
inform
regard
outcom
extract
daili
januari
april
worldomet
websit
demograph
measur
countri
extract
worldomet
websit
april
inform
regard
share
popul
year
econom
develop
indic
extract
world
bank
data
preval
chronic
diseas
eg
obes
type
diabet
tuberculosi
death
rate
cardiovascular
disord
extract
world
data
websit
supplement
tabl
provid
sourc
countryrel
inform
inform
regard
past
present
bcg
administr
practic
everi
countri
extract
bcg
world
atla
two
vaccin
statu
group
consid
first
group
includ
countri
either
current
past
nation
mandatori
vaccin
polici
countri
second
group
includ
countri
administ
bcg
vaccin
specif
group
risk
countri
percentag
peopl
risk
immun
total
popul
size
neglig
addit
estim
bcg
vaccin
coverag
year
extract
annual
report
addit
resourc
use
establish
year
mandatori
bcg
administr
see
supplement
tabl
extend
descript
data
collect
data
imput
data
process
see
supplement
method
data
normal
perform
countri
account
relev
popul
size
includ
analysi
death
per
million
dpm
case
hospit
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
seriou
critic
spm
case
per
million
cpm
countri
includ
select
cohort
popul
met
criteria
death
per
popul
april
countri
cohort
seen
supplement
tabl
account
vari
time
diseas
across
countri
defin
unifi
align
key
date
countri
first
date
dpm
reach
first
time
valu
higher
follow
analysi
conduct
across
chang
date
eg
day
key
align
date
defin
countryspecif
group
binari
categor
bcg
administr
appli
rank
wilcoxon
test
nonparametr
statist
test
compar
pair
group
continu
ie
number
year
bcg
administ
preval
tb
popul
median
age
data
appli
linear
regress
report
regress
fit
calcul
statist
signific
pvalu
outcom
correl
bcg
age
group
determin
partit
popul
countri
three
group
year
younger
ii
year
iii
year
older
age
partit
bcg
coverag
within
age
group
valu
measur
percentag
popul
share
age
group
bcg
calcul
see
supplement
materi
method
onlin
tool
display
analyt
result
avail
http
code
data
avail
http
analyz
trend
pandem
across
differ
countri
prone
variabl
actual
date
countri
expos
fatal
recogn
report
increas
robust
analys
focus
countri
minim
size
popul
mandatori
dpm
analysi
date
april
altogeth
countri
cover
world
popul
compli
threshold
region
partit
countri
shown
fig
detail
inform
countri
includ
analys
see
supplement
tabl
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
first
analyz
outcom
differ
death
per
million
dpm
case
per
million
cpm
fig
show
strong
signific
correl
outcom
year
bcg
administr
analysi
perform
day
follow
differ
align
key
date
defin
dpm
dpm
among
countri
data
inform
day
observ
strong
neg
correl
dpm
cpm
function
bcg
admiss
year
dpm
outcom
observ
correl
r
pvalu
align
dpm
fig
r
pvalu
align
dpm
fig
similarli
consid
cpm
rather
dmp
result
similar
trend
slightli
lower
correl
statist
strength
specif
day
post
align
observ
correl
r
pvalu
align
dpm
fig
r
pvalu
align
dpm
fig
repeat
analysi
variou
time
point
along
progress
diseas
eg
day
align
key
date
result
similar
trend
highli
signific
neg
correl
outcom
year
bcg
administr
note
day
post
key
align
data
mani
countri
provid
inform
countri
mainli
latin
america
earlier
phase
pandem
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
key
date
defin
cpm
c
cpm
dpm
diff
cpm
diff
calcul
differ
number
measur
date
align
date
test
gener
observ
repeat
analysi
broad
rang
time
point
along
progress
diseas
differ
countri
start
day
post
align
key
date
show
trend
day
interv
fig
analysi
test
outcom
confirm
case
cpm
number
recov
rpm
addit
dpm
spm
result
dpm
spm
show
high
signific
associ
time
point
exclud
last
time
point
present
limit
statist
signific
base
data
countri
countri
differ
mani
aspect
like
popul
size
gross
domest
product
gdp
life
span
order
control
potenti
confound
factor
includ
numer
demograph
valu
multivari
linear
regress
result
show
number
bcg
administr
year
rank
significantli
within
coeffici
larger
effect
measur
normal
beta
coeffici
coeffici
fig
result
consist
among
differ
time
observ
daysrank
largest
pvalu
beta
daysrank
larger
effect
pvalu
beta
daysrank
largest
effect
pvalu
beta
unsurprisingli
strong
posit
beta
coeffici
associ
median
age
cancer
percentag
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
also
signific
contribut
comorbid
multivari
analysi
call
futur
analysi
beta
coeffici
normal
multivari
linear
regress
shown
blue
line
repres
coeffici
confid
interv
pvalu
ad
variabl
pvalu
next
investig
relev
age
group
observ
show
year
bcg
admiss
strongli
correl
better
outcom
fig
inspect
age
partit
popul
countri
evid
countri
differ
drastic
median
age
instanc
ecuador
median
age
year
itali
fig
show
correl
total
year
bcg
admiss
within
given
timefram
age
group
accord
countrybas
age
composit
day
post
align
key
date
popul
countri
partit
young
year
age
work
class
year
old
year
across
sever
time
point
strongest
correl
bcg
coverag
age
depend
associ
young
group
fig
follow
work
class
group
fig
correl
young
age
group
test
day
highli
signific
r
pvalu
highli
statist
signific
neg
trend
repeat
among
date
test
within
day
post
align
correl
age
group
year
test
day
also
signific
r
weaker
signific
pvalu
neg
trend
day
observ
signific
eg
daysr
pvalu
interestingli
old
age
group
correl
neglig
insignific
fig
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
fig
correl
rel
bcg
coverag
dpm
diff
among
vari
age
group
correl
measur
day
follow
align
key
date
rel
bcg
coverag
within
young
age
group
rel
bcg
coverag
within
work
class
age
group
b
rel
bcg
coverag
within
old
age
group
c
dpm
diff
countri
gray
partial
yellow
blue
roll
immun
program
past
year
statist
signific
valu
shown
pronounc
signal
young
age
group
led
us
investig
whether
recent
immun
may
posit
effect
outcom
whether
signal
may
due
proxim
age
group
young
time
vaccin
efficaci
bcg
tb
expect
span
approxim
year
therefor
divid
countri
disjoin
group
repres
vaccin
polici
past
year
countri
mandatori
immun
polici
past
year
ii
countri
mandatori
immun
polici
less
year
within
past
year
iii
countri
mandatori
immun
polici
past
year
appli
kruskalw
test
outcom
dpm
yield
highli
signific
result
rang
test
date
post
align
day
establish
countri
immun
polici
past
year
significantli
lower
rate
dpm
respect
countri
group
iii
fig
show
result
day
post
align
pvalu
fulli
treat
group
non
treat
group
iii
group
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
provid
interact
websit
http
provid
use
analyt
webtool
singl
variant
statist
correl
multivari
analys
user
friendli
platform
allow
user
chang
paramet
along
pandem
progress
select
predetermin
outcom
refer
date
align
signific
strong
correl
bcg
vaccin
better
outcom
shown
across
mani
countri
cover
major
world
popul
find
base
unbias
view
countri
compli
predetermin
threshold
minimum
number
dpm
popul
size
see
materi
method
anticip
progress
pandem
countri
earli
phase
pandem
could
includ
importantli
strong
neg
correl
bcg
admiss
year
dpm
sustain
rang
timepoint
fig
trend
similar
dpm
account
peopl
hospit
seriou
critic
condit
spm
neg
correl
posit
case
cpm
weaker
rel
dpm
reflect
vari
capac
differ
countri
carri
molecular
test
lung
ct
patholog
test
importantli
polici
test
greatli
vari
weaker
confid
observ
peopl
recov
rpm
assum
reflect
earli
stage
pandem
mani
countri
furthermor
nonstandard
definit
confirm
recoveri
like
reduc
reliabl
rpm
eventu
affect
statist
power
multivari
analysi
highlight
strength
combin
broad
rang
countrybas
quantit
observ
eg
econom
measur
number
doctor
per
peopl
popul
composit
includ
habit
smoke
exposur
infecti
diseas
preval
tb
sever
major
comorbid
eg
cancer
diabet
mani
individu
measur
correl
may
reflect
confound
factor
instanc
countri
suffer
high
level
tb
also
mark
high
immigr
social
inequ
high
drug
alcohol
abus
hiv
infect
importantli
multivari
analysi
valid
import
statist
signific
bcg
immun
year
given
variabl
attribut
better
outcom
expect
median
age
also
extrem
signific
higher
valu
strongli
contribut
wors
outcom
detail
inform
number
bcg
admiss
year
use
addit
sourc
inform
unavail
binari
definit
bcg
immun
consid
detail
inform
exact
year
first
admiss
health
polici
countri
actual
immun
coverag
provid
allow
thorough
inspect
bcg
vaccin
popul
structur
fig
explicitli
test
compon
bcg
immun
critic
outcom
partit
popul
young
middl
elderli
age
group
confirm
strongest
signal
toward
outcom
associ
young
year
middl
age
year
elderli
year
highest
risk
mortal
correl
bcg
higher
coverag
implic
observ
epidemiolog
evid
like
countri
young
popul
year
vaccin
maxim
protect
provid
univers
dpm
among
young
peopl
low
year
main
contribut
express
sustain
chain
infect
higher
coverag
young
lead
lower
death
toll
elderli
popul
probabl
due
lower
rate
infect
caus
young
group
lead
overal
lower
death
toll
lack
correl
bcg
coverag
year
outcom
accord
expect
neglig
impact
elderli
popul
transmiss
within
commun
ccbync
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
sever
report
propos
bcg
vaccin
popul
partial
protect
virus
gener
particular
despit
broad
usag
bcg
almost
centuri
longterm
effect
bcg
immun
system
remain
enigmat
bcg
report
protect
function
variou
pathogen
argu
act
gener
system
immunolog
stimul
indirect
effect
bcg
diabet
multipl
sclerosi
allcaus
mortal
children
develop
countri
report
argu
base
agepartit
analysi
recent
immun
mani
countri
rather
longterm
heterolog
effect
domin
strong
statist
signific
valu
bcg
effect
recent
immun
popul
year
fig
support
hypothesi
better
outcom
govern
recent
bcg
immun
altern
view
suggest
lifetim
activ
system
await
addit
evid
conclud
strong
neg
correl
bcg
administr
year
impact
recent
vaccin
valid
role
young
popul
spread
fundament
observ
revisit
global
nation
bcg
immun
polici
present
recommend
bcg
vaccin
prevent
sever
clinic
trial
bcg
undertaken
